Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient's tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 0794T refers to a patient-specific, assistive, rules-based algorithm designed to rank pharmaco-oncologic treatment options tailored to the individual patient's tumor-specific cancer marker information. This information is derived from prior molecular pathology, immunohistochemical, or other pathology results that have been previously interpreted and reported separately. The algorithm is instrumental in providing a systematic approach to evaluating available treatment options, ensuring that the ranking is based solely on FDA-approved drugs. The process begins with the physician or qualified healthcare professional compiling all relevant clinical data specific to the patient's tumor, which includes previously interpreted results from molecular, laboratory, and pathology tests. Importantly, any raw data from genomic sequencing is excluded from this analysis. The output of the algorithm is a comprehensive report that ranks potential therapies, enabling the physician to make informed decisions regarding subsequent treatment plans aimed at effectively targeting the patient's specific cancer.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The use of CPT® Code 0794T is indicated for patients who require a tailored approach to their cancer treatment based on specific tumor characteristics. The following conditions warrant the application of this algorithm:

  • Patient-Specific Cancer Markers Patients with tumor-specific cancer markers that have been previously identified through molecular pathology or immunohistochemical testing.
  • Prior Pathology Results Individuals whose cancer treatment options need to be informed by previously interpreted and reported pathology results.
  • Need for Targeted Therapy Patients who are candidates for targeted therapies that align with their specific cancer profile, ensuring the use of FDA-approved drugs.

2. Procedure

The procedure associated with CPT® Code 0794T involves several key steps that ensure the effective ranking of treatment options based on the patient's unique cancer characteristics. Each step is crucial for the accurate application of the algorithm:

  • Step 1: Data Collection The physician or qualified healthcare professional gathers all relevant clinical data pertaining to the patient's tumor. This includes previously interpreted results from molecular pathology, laboratory tests, and immunohistochemical analyses. It is essential that this data is comprehensive and specific to the patient's cancer markers.
  • Step 2: Exclusion of Raw Genomic Data During the data collection process, any raw data from genomic sequencing is explicitly excluded. This ensures that the algorithm operates solely on interpreted results, which have been validated and reported separately, maintaining the integrity of the analysis.
  • Step 3: Algorithm Application The collected data is then input into the patient-specific, assistive algorithm. This rules-based system processes the information to evaluate and rank available treatment options, focusing on both single drug therapies and combination therapies that are FDA-approved.
  • Step 4: Report Generation Upon completion of the algorithmic analysis, a detailed report is generated. This report outlines the ranked treatment options, providing the physician with a clear overview of the most suitable therapies tailored to the patient's specific cancer profile.
  • Step 5: Treatment Planning Finally, the physician reviews the algorithm-generated report to inform subsequent treatment decisions. This step is critical as it allows for a strategic approach to therapy, ensuring that the selected treatments are aligned with the patient's unique tumor characteristics.

3. Post-Procedure

After the application of CPT® Code 0794T and the generation of the treatment ranking report, the physician will engage in a discussion with the patient regarding the recommended treatment options. This may involve explaining the rationale behind the selected therapies and addressing any questions or concerns the patient may have. The physician will then proceed to implement the chosen treatment plan, monitoring the patient's response to therapy and making adjustments as necessary based on ongoing evaluations and clinical outcomes. Continuous follow-up is essential to ensure that the treatment remains effective and aligned with the patient's evolving clinical status.

Short Descr PT SPEC ALG RX-ONC TX OPTION
Medium Descr PT SPEC ALG RANKING PHARMACOONCOLOGIC TX OPTIONS
Long Descr Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient's tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately
Status Code Carriers Price the Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 3 - Technical Component Only Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Not Discounted when Multiple
Berenson-Eggers TOS (BETOS) none
MUE 1
Date
Action
Notes
2024-01-01 Added First appearance in code book.
2023-07-01 Added Code added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"